March 22 (Reuters) - U.S. health insurer Centene Corp on Tuesday named Vice Chairman Sarah London as its new chief executive officer, replacing Michael Neidorff, who is on medical leave. Prior to joining Humedica, Ms. London was part of the team that launched Accretive Health's Quality & Total Cost of Care business, providing end-to-end population health strategy and operational consulting to leading medical centers around the country. Sarah London Age : 42 Public asset : 24,128,130 USD Country of residence : Unknown Linked companies : Centene Corporation Biography of Sarah London Presently, Sarah London is President-Health Care Enterprises at Centene Corp. Of this total $0 was received as a salary, $0 was received as a bonus, $0 was received in stock options, $0 was awarded as stock and $0 came from other types of compensation. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs. Together, we can deliver innovative, integrated, and equitable care that meets our members where they live and exceeds their expectations. By Tony Mecia. Prior to joining Humedica, Ms. London was part of the team that launched Accretive Health's Quality & Total Cost of Care business, providing end-to-end population health strategy and operational consulting to leading medical centers around the country. "Centene expects to lose an estimated 2.2 million Medicaid members during the redetermination process over the next 18 months, which would significantly dial Currently, Sarah London works as a Chief Executive Officer at Centene. All rights reserved. London, who has been vice chairman of Centenes board, has led the companys technology and digital strategy while also running the health insurers health care enterprises and specialty divisions, corporate strategy, quality operations, internal audit, compliance and risk management, the company said. January 12, 2022, 8:01 AM Sarah London, Vice Chairman of Centene, joins Yahoo Finance Live to talk about Centene's health care initiatives, CMS changes, and how they are handling COVID-19. 1. She started in data analytics at Optum and later was a partner in its venture capital arm. Ms London is 40, she's been the Pres of Health Care Enterprises & Exec. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to:our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully;restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. Schwaneke will report to Sarah London, President, Health Care Enterprises and Executive Vice President, Advanced Technology, HealthCare Enterprises. Subscriber only . Centene Announces Organizational Enhancements, Establishes - Insider March 23, 2022 at 10:20 AM Author of the article: Reuters . I'm excited by the tremendous opportunity to leverage the size and scale of this Company to create true, sustaining value for our members, state partners, employees and shareholders.". Chief Financial Officer. The board of Centene has picked Sarah London an executive with roots in venture capital and talent. This morning we reported second quarter revenues at $27.7 billion, an increase of 51% over the second quarter of 2019. from 8 AM - 9 PM ET. 396 Ratings. Centene CEO Sarah London joined CNBC 's Power Lunch with Bertha Coombs to discuss Centene's local approach as a differentiator, its data-driven strategies to enhance health outcomes, and. 48% of all employees identify as people of color, including 36% at the supervisory + level. See reviews, salaries & interviews from Centene employees in MISSING VALUE. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, afterthe date hereof. She soon moved to Humedica, a data analytics company. Managed care members jumped 1.1 million to 26.6 million. Sarah London - Senior Manager, Global Meetings & Events - LinkedIn Forward-Looking StatementsAll statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Nov 2013 - Mar 20173 years 5 months. MH magazine offers content that sheds light on healthcare leaders complex choices and touch pointsfrom strategy, governance, leadership development and finance to operations, clinical care, and marketing. The most active insiders traders include Michael F Neidorff, Frederick H Eppinger, and Edward L Cahill. He continues to be the chairman. Brent Layton, President and Chief Operating Officer of Centene, stated, "Sarah brings a tremendous skillset to the leadership of Centene Corporation, and I'm excited to partner closely with her as Centene begins our journey into the next era of our history. Centene fell about 1.4% to close at $75.34 in New York on Wednesday, giving the St. Louis-based company a market value of about $44 billion. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in completed and future acquisitions, including statements about the impact of our recently completed acquisition of Magellan Health (the Magellan Acquisition), other recent and future acquisitions and dispositions, investments and the adequacy of our available cash resources. She joined a four-member office of the chairman in February, when Centene announced that Neidorff was taking a leave of absence to deal with a medical condition. The company will report its 2022 first quarter earnings on April. Jim Murray. According to ZoomInfo records, Sarah London's professional experience began in 2012. London is also dedicated to prioritizing wellness for employees, including through enhanced caregiver benefits. Before joining Centene in 2020, Ms. London was a Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. Employees in the top 10 percent can make over $103,000 per year, while employees at the bottom 10 percent earn less than $33,000 per year. Neidorff turned it into a national player by competing aggressively for state Medicare contracts. Centene Reviews: What Is It Like to Work At Centene? | Glassdoor Ms. London received a Bachelor of Arts in history and literature from Harvard College and a Master of Business Administration from the University of Chicago Booth School of Business. Centene Vice Chair Sarah London Adds CEO Title - GovCon Wire Centene focuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners. Employees in the business development department receive relatively high salaries as well, where wages average $91,494 per year. California Weighs $360,000 in Reparations to Eligible Black Residents. Total Cash Compensationinformation is comprised of yearly Base Pay and Bonuses. The national average salary for a Centene employee in the United States is $58,575 per year. Carla Padilla on LinkedIn: Sarah London | 2022 Most Powerful Women Centene taps London to succeed Michael Neidorff as CEO Centene shuffled its senior management ranks Wednesday, elevating Ken Fasola to become president of the health insurer, reporting to chief executive officer Sarah London. Average Centene hourly pay ranges from approximately $13.23 per hour for Quality Assurance Engineer to $54.71 per hour for Senior Case Manager. London started at Optum as the chief product officer at Optum Analytics. Associate Professor . Ms. London previously served as Vice President of Client Services & Operations with Humedica, a venture-backed healthcare data and analytics company acquired by Optum in 2013. Effective with her election as Vice Chairman, Ms. London will have a base salary of $1,250,000 and a target annual cash bonus of 150% of her base salary. Centene generated revenue of $126 billion in 2021, a 13% increase over the year prior as more people were enrolled in Medicaid plans following the pandemic. London played Division I tennis at Harvard. Working at Centene | Glassdoor Prior to Optum Ventures, Ms. London served as Chief Product Officer for Optum Analytics, the business unit responsible for driving strategy and commercialization of Optum's integrated data and analytics solutions into the provider, payer and life sciences markets. Centene Salaries trends. Executive Leadership | Centene Corporation Under Neidorff, Centene has grown into a national healthcare giant with revenues that eclipsed $126 billion in 2021 as more Americans sign up for Medicaid, the health insurance for low income patients it manages via contracts with states and individual coverage under the ACA known as Obamacare hits record levels. Sarah's mailing address filed with the SEC is 7700, Forsyth Boulevard, Clayton, Saint Louis County, Missouri, 63105, United States. This is the Centene company profile. The average Centene salary ranges from approximately $36,879 per year for Senior Customer Service Representative to $172,832 per year for Vice President of Compliance. All content is posted anonymously by employees working at Centene. "I am delighted that the Board has appointed Sarah as CEO. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. Sarah M London, Centene Corp: Profile and Biography In this episode, Bronson explains how the lessons he learned in the kitchen translated to the booth, the reason money can never be the motivation for creating art, and why he believes that imperfections are the best part of any masterpiece. Will Others Follow? Chicago/NYC. and strategy roles with the health insurer, the company said March 22, 2022. 2023 Women Leaders Sarah London | Modern Healthcare Her strategic thinking, fresh perspective and diverse experience make her the natural leader to harness the potential of Centene," Centenes Acting Chairman, James Dallas said in a statement. The most recent stock trade was executed by Andrew Lynn Asher on 9 February 2023, trading 6,800 units of CNC stock currently worth $489,124. Listen to free podcasts to get the info you need to solve business challenges! Executive Compensation Data Year: Trend Analysis As at CENTENE CORP, made $0 in total compensation. Effective September 7, 2021, the Board of Directors (the "Board") of Centene Corporation (the "Company") elected Sarah M. London as Vice Chairman of the Board of Directors of Centene Corporation and Brent D. Layton as the Company's President and Chief Operating Officer. Sarah London - Chief Executive Officer - Centene | ZoomInfo "Sarah has infused an innovative mindset across the enterprise in her relentless effort to improve Centene's capabilities to provide the highest quality of care for our members. Centene Company Profile | Management and Employees List - Datanyze Centene Appoints Sarah London As Chief Executive Officer London succeeds Michael Neidorff, who went on medical leave late last month, the company said. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. By continuing to use our site, you agree to our Privacy Policy and Terms and Conditions. This Supreme Court Case Could Redefine Crime, YellowstoneBackers Wanted to Cash OutThen the Streaming Bubble Burst, How Countries Leading on Early Years of Child Care Get It Right, Female Execs Are Exhausted, Frustrated and Heading for the Exits, No Major Offer Expected on Childcare in UK Budget, Biden Gives Medal of Honor to Trailblazing Special Forces Member, Climate Change Is Launching a MutantSeed Space Race, UK Braces for Rare Weather Event That Risks Late-Winter Freeze, This Former Factory Is Now New Taipeis Edgiest Project, What Do You Want to See in a Covid Memorial? ST. LOUIS, March 22, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. Centene Centene has promoted Sarah London, the health insurance company's current board vice chair, to the job as Chief Executive Officer, succeeding the retiring Michael Neidorff, the. FORTUNE magazine continuously ranks us as one of America's fastest-growing companies. She started in data analytics at Optum and later was a partner in its venture capital arm. And Centene has expanded into the business of Medicare Advantage, the privatized health benefits myriad health insurers offer senior via contract with the federal government. Prior to being appointed Chief Executive Officer in 2022, she served as Centene's Vice Chairman, responsible for strategy, technology, pharmacy. In a March 31 regulatory filing, Centene said its board of directors had approved a compensation package for new CEO Sarah London with an annual base salary of $1.4 million and a cash. Health insurer Centene names Sarah London as new CEO Women represent 76% of our employees and 65% of employees in supervisory positions. CENTENE CORP : Change in Directors or Principal - MarketScreener Jan 3, 2023 09:43pm. Health insurer Centene names Sarah London as new CEO ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. Drew Asher. Biography. . Health insurer Centene names Sarah London as new CEO Back to video. CNC Company Profile & Executives - Centene Corp. - The Wall Street Journal The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Sarah London, vice chairman of the board of directors at Centene (NYSE: CNC), has accepted additional responsibilities as CEO of the St. Louis-based health insurer. Centene CEO outlines plans for massive Charlotte campus; commits to Ms. London has spent her career at the intersection of health data, technology, and the transformation of value-based care for vulnerable Americans with the greatest needs. "The healthcare landscape is rapidly changing, and Centene's mission to transform the health of our communities one member at a time has never been more relevant. Centene appoints venture capital veteran as new CEO - Charlotte Region Ms. London began her healthcare career at Health Leads, a nationally-recognized social enterprise that partners with healthcare organizations to address social determinants of health by connecting patients to the community-based resources needed to support high-quality, cost-effective health outcomes. You may also find the annual proxy statement by going directly to the company's website. Centene Profile and History . March 22 (Reuters) - U.S health insurer Centene Corp CNC.N on Tuesday named Vice Chairman Sarah London as its new chief executive officer, effective immediately. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. Neidorff remains on a previously announced medical leave of absence from his position on the board of the company. Brent Layton, President and Chief Operating Officer of Centene, stated, "Sarah brings a tremendous skillset to the leadership of Centene Corporation, and I'm excited to partner closely with her as Centene begins our journey into the next era of our history. Her strategic thinking, fresh perspective and diverse experience make her the natural leader to harness the potential of Centene, Dallas said. Copyright 2023 Surperformance. ST. LOUIS, March 22, 2022 /PRNewswire/ --Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. Centene Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans.
Close